Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Medical Device Market

ID: MRFR/MED/42597-HCR
200 Pages
Rahul Gotadki
Last Updated: April 06, 2026

France Medical Device Market Research Report By Device Type Outlook (Drug Delivery System, Diagnostic Devices, Invasive Devices, Respiratory Therapeutic Devices, Electronic Medical Device, Others), By Application Outlook (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, Ophthalmology, General Surgery, Respiratory, Dental, Ear, Nose, and Throat (ENT), Neurology, Nephrology Urology, Others) and By End User Outlook (Hospitals Clinics, Ambulatory Surgical Centers, Homecare Settings, Others) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

France Medical Device Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Billion)
  49.     4.1.1 Surgical Devices
  50.     4.1.2 Diagnostic Imaging
  51.     4.1.3 Patient Monitoring
  52.     4.1.4 Therapeutic Devices
  53.     4.1.5 In Vitro Diagnostics
  54.   4.2 Healthcare, BY End Use (USD Billion)
  55.     4.2.1 Hospitals
  56.     4.2.2 Clinics
  57.     4.2.3 Home Care
  58.     4.2.4 Ambulatory Surgical Centers
  59.     4.2.5 Diagnostic Laboratories
  60.   4.3 Healthcare, BY Product Type (USD Billion)
  61.     4.3.1 Surgical Instruments
  62.     4.3.2 Imaging Equipment
  63.     4.3.3 Monitoring Devices
  64.     4.3.4 Therapeutic Equipment
  65.     4.3.5 Consumables
  66.   4.4 Healthcare, BY Technology (USD Billion)
  67.     4.4.1 Electronics
  68.     4.4.2 Biotechnology
  69.     4.4.3 Nanotechnology
  70.     4.4.4 Robotics
  71.     4.4.5 Materials Science
  72.   4.5 Healthcare, BY Regulatory Classification (USD Billion)
  73.     4.5.1 Class I
  74.     4.5.2 Class II
  75.     4.5.3 Class III
  76.     4.5.4 Class IV
  77. 5 SECTION V: COMPETITIVE ANALYSIS
  78.   5.1 Competitive Landscape
  79.     5.1.1 Overview
  80.     5.1.2 Competitive Analysis
  81.     5.1.3 Market share Analysis
  82.     5.1.4 Major Growth Strategy in the Healthcare
  83.     5.1.5 Competitive Benchmarking
  84.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  85.     5.1.7 Key developments and growth strategies
  86.       5.1.7.1 New Product Launch/Service Deployment
  87.       5.1.7.2 Merger & Acquisitions
  88.       5.1.7.3 Joint Ventures
  89.     5.1.8 Major Players Financial Matrix
  90.       5.1.8.1 Sales and Operating Income
  91.       5.1.8.2 Major Players R&D Expenditure. 2023
  92.   5.2 Company Profiles
  93.     5.2.1 Medtronic (US)
  94.       5.2.1.1 Financial Overview
  95.       5.2.1.2 Products Offered
  96.       5.2.1.3 Key Developments
  97.       5.2.1.4 SWOT Analysis
  98.       5.2.1.5 Key Strategies
  99.     5.2.2 Boston Scientific (US)
  100.       5.2.2.1 Financial Overview
  101.       5.2.2.2 Products Offered
  102.       5.2.2.3 Key Developments
  103.       5.2.2.4 SWOT Analysis
  104.       5.2.2.5 Key Strategies
  105.     5.2.3 Abbott Laboratories (US)
  106.       5.2.3.1 Financial Overview
  107.       5.2.3.2 Products Offered
  108.       5.2.3.3 Key Developments
  109.       5.2.3.4 SWOT Analysis
  110.       5.2.3.5 Key Strategies
  111.     5.2.4 Johnson & Johnson (US)
  112.       5.2.4.1 Financial Overview
  113.       5.2.4.2 Products Offered
  114.       5.2.4.3 Key Developments
  115.       5.2.4.4 SWOT Analysis
  116.       5.2.4.5 Key Strategies
  117.     5.2.5 Stryker Corporation (US)
  118.       5.2.5.1 Financial Overview
  119.       5.2.5.2 Products Offered
  120.       5.2.5.3 Key Developments
  121.       5.2.5.4 SWOT Analysis
  122.       5.2.5.5 Key Strategies
  123.     5.2.6 Siemens Healthineers (DE)
  124.       5.2.6.1 Financial Overview
  125.       5.2.6.2 Products Offered
  126.       5.2.6.3 Key Developments
  127.       5.2.6.4 SWOT Analysis
  128.       5.2.6.5 Key Strategies
  129.     5.2.7 Philips Healthcare (NL)
  130.       5.2.7.1 Financial Overview
  131.       5.2.7.2 Products Offered
  132.       5.2.7.3 Key Developments
  133.       5.2.7.4 SWOT Analysis
  134.       5.2.7.5 Key Strategies
  135.     5.2.8 B. Braun Melsungen AG (DE)
  136.       5.2.8.1 Financial Overview
  137.       5.2.8.2 Products Offered
  138.       5.2.8.3 Key Developments
  139.       5.2.8.4 SWOT Analysis
  140.       5.2.8.5 Key Strategies
  141.     5.2.9 GE Healthcare (US)
  142.       5.2.9.1 Financial Overview
  143.       5.2.9.2 Products Offered
  144.       5.2.9.3 Key Developments
  145.       5.2.9.4 SWOT Analysis
  146.       5.2.9.5 Key Strategies
  147.   5.3 Appendix
  148.     5.3.1 References
  149.     5.3.2 Related Reports
  150. 6 LIST OF FIGURES
  151.   6.1 MARKET SYNOPSIS
  152.   6.2 FRANCE MARKET ANALYSIS BY APPLICATION
  153.   6.3 FRANCE MARKET ANALYSIS BY END USE
  154.   6.4 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
  155.   6.5 FRANCE MARKET ANALYSIS BY TECHNOLOGY
  156.   6.6 FRANCE MARKET ANALYSIS BY REGULATORY CLASSIFICATION
  157.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  158.   6.8 RESEARCH PROCESS OF MRFR
  159.   6.9 DRO ANALYSIS OF HEALTHCARE
  160.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  161.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  162.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  163.   6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  164.   6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
  165.   6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
  166.   6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Billion)
  167.   6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
  168.   6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
  169.   6.19 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
  170.   6.20 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
  171.   6.21 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 (% SHARE)
  172.   6.22 HEALTHCARE, BY REGULATORY CLASSIFICATION, 2024 TO 2035 (USD Billion)
  173.   6.23 BENCHMARKING OF MAJOR COMPETITORS
  174. 7 LIST OF TABLES
  175.   7.1 LIST OF ASSUMPTIONS
  176.     7.1.1
  177.   7.2 France MARKET SIZE ESTIMATES; FORECAST
  178.     7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  179.     7.2.2 BY END USE, 2026-2035 (USD Billion)
  180.     7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Billion)
  181.     7.2.4 BY TECHNOLOGY, 2026-2035 (USD Billion)
  182.     7.2.5 BY REGULATORY CLASSIFICATION, 2026-2035 (USD Billion)
  183.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  184.     7.3.1
  185.   7.4 ACQUISITION/PARTNERSHIP
  186.     7.4.1

France Healthcare Market Segmentation

Healthcare By Application (USD Billion, 2026-2035)

  • Surgical Devices
  • Diagnostic Imaging
  • Patient Monitoring
  • Therapeutic Devices
  • In Vitro Diagnostics

Healthcare By End Use (USD Billion, 2026-2035)

  • Hospitals
  • Clinics
  • Home Care
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

Healthcare By Product Type (USD Billion, 2026-2035)

  • Surgical Instruments
  • Imaging Equipment
  • Monitoring Devices
  • Therapeutic Equipment
  • Consumables

Healthcare By Technology (USD Billion, 2026-2035)

  • Electronics
  • Biotechnology
  • Nanotechnology
  • Robotics
  • Materials Science

Healthcare By Regulatory Classification (USD Billion, 2026-2035)

  • Class I
  • Class II
  • Class III
  • Class IV

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓